SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QGLY - Funny Name Great Product. -- Ignore unavailable to you. Want to Upgrade?


To: drakes353 who wrote (7158)1/9/1998 9:20:00 AM
From: John A Satriano  Read Replies (2) | Respond to of 8960
 
I wonder how long this SB-2 thing can get drawn out... by posters that is. I can see it now, sometime in 2007 some poster will be on this board saying "as soon as that SB-2 gets deemed effective, my short position is gold!"

If the SB-2 is really what you claim it is, what possible reason on earth would there be for not having it 'deemed effective' already? If these shareholders were so desperate to sell 5 million shares 6 months ago, what are they waiting for? You (and others) have accused Q of 'dragging their feet' on the SB-2. So far, they have dragged while the stock price went from 23 to 13 1/2.

Isn't all of this starting to sound just a little bit silly to anyone?

J.S.



To: drakes353 who wrote (7158)1/9/1998 11:14:00 AM
From: Will Preska  Respond to of 8960
 
Let's not lose sight of what Guy is saying. The 20% growth is based exclusively on domestic sales.

'' Additional growth is also possible in international markets, and the company is presently evaluating proposed international distribution agreements to obtain the best possible international partners,'' Guy Quigley, company chairman, said in the release.

- Will